(Q39874719)
Statements
Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model (English)
Evelien W Duiker
Devalingam Mahalingam
Gert Jan Meersma
Wytske Boersma-van Ek
Harry Hollema
Marjolijn N Lub-de Hooge
Go M van Dam
Wim J Quax
Ate G J van der Zee
Steven de Jong
10 March 2009